Insider Holders & Insider Ownership - Entasis Therapeutics Holdings Inc. (ETTX)

List of insiders holdings for Entasis Therapeutics Holdings Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Innoviva Inc.
Innoviva Strategic Opportunities LLC
10% Owner
2022-07-13 21:27:3437,345,794
39,270,476
76,616,270Form 4
ASTRAZENECA PLC
ASTRAZENECA AB
10% Owner
2018-10-12 11:10:452,164,855
0
2,164,855Form 13D
Blackstone Holdings II L.P.
Blackstone Clarus III L.L.C.
Blackstone Holdings I
Blackstone Group L.P.
Blackstone Group Management L.L.C.
SCHWARZMAN STEPHEN A
10% Owner
2019-01-15 09:25:300
1,623,405
1,623,405Form 3
Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
2020-07-09 16:48:591,339,836
0
1,339,836Form 13D
Pivotal bioVenture Partners Fund I L.P.
Pivotal bioVenture Partners Fund I G.P. L.P.
Pivotal bioVenture Partners Fund I U.G.P. Ltd
10% Owner
2018-12-21 21:10:341,180,178
0
1,180,178Form 13D
Novo Holdings A/S
10% Owner
2020-08-11 16:30:531,173,896
0
1,173,896Form 13G
TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
Former 10% Owner
2018-10-09 17:05:571,020,748
0
1,020,748Form 13D
Frazier Life Sciences VIII L.P.
Topper James N
FHM LIFE SCIENCES VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
10% Owner
2020-06-18 12:30:03799,953
0
799,953Form 13D
Gutch Michael
See Remarks
2022-02-15 16:05:0875,404
0
75,404Form 4
Isaacs Robin
Chief Medical Officer
2019-01-22 17:00:1156,500
0
56,500Form 4
Kimble Eric Wilson
Chief Commercial Officer
2020-01-27 16:06:3350,000
0
50,000Form 4
GALAKATOS NICHOLAS
Director
2019-06-21 16:02:527,500
0
7,500Form 4
Preston Heather
Director
2019-06-21 16:03:077,500
0
7,500Form 4
Norden Gregory
Director
2019-06-21 16:03:527,500
0
7,500Form 4
HASTINGS DAVID C
Director
2022-07-11 16:05:270
0
0Form 4
Staples Andrew J.
Director
2018-09-25 20:50:560
0
0Form 3
Wagner Kristie Ann
VP, Principal Fin & Acct Off
2022-07-11 16:11:000
0
0Form 4
Triola Anna Diaz
Chief Commercial Officer
2022-07-11 16:10:150
0
0Form 4
Tommasi Ruben
Chief Scientific Officer
2022-07-11 16:09:410
0
0Form 4
Ronsheim Matthew
Chief of Pharma Sciences & MFG
2022-07-11 16:09:040
0
0Form 4
Perros Manoussos
President and CEO
2022-07-11 16:08:290
0
0Form 4
Mueller John Patrick
Chief Development Officer
2022-07-11 16:07:570
0
0Form 4
Meek David D.
Director
2022-07-11 16:07:220
0
0Form 4
Mayer Howard
Director
2022-07-11 16:06:510
0
0Form 4
Keiley Elizabeth M
General Counsel
2022-07-11 16:06:010
0
0Form 4
Berger Heather A.
Director
2022-07-11 16:04:560
0
0Form 4
Altarac David
Chief Medical Officer
2022-07-11 16:03:490
0
0Form 4
Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
HEALY JAMES
Mehra Anand
POWELL MICHAEL
10% Owner
2021-03-04 06:17:320
0
0Form 13D